Bright Minds Biosciences(us:DRUG)

36.07

-1.18%

Updated on 2025-03-31

Open:36.50
Close:36.07
High:38.33
Low:35.22
Prev Close:36.50
Volume:42355.00
Turnover:1.56M
Turnover Ratio:0.60%
Shares:7.04M
MarketCap:254.08M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3071975404.43%013
2024-03-31112133754.78%315
2023-12-3182283605.12%231
2023-09-30111946015.16%317
2023-06-30111147430.61%225
2023-03-31105836343.09%231
2022-12-31154082402.18%128
2022-09-30164129092.35%624
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Advisorshares Investments Llc1760383.94%-12081-6.42%
2024-03-31Citadel Advisors Llc178290.40%17829
2024-03-31Jane Street Group, Llc137950.31%13795
2024-03-31National Bank Of Canada /Fi/50000.11%5000
2024-03-31Royal Bank Of Canada6120.01%334120.14%
2024-03-31Aspire Private Capital, Llc1000.00%0
2024-03-31Blackrock Inc.10
2024-03-31Virtu Financial Llc0-10399
2024-03-31Renaissance Technologies Llc0-11996
2024-03-31Ubs Group Ag0-622

About

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.
Address:19 Vestry Street

Market Movers